sglt2 vs glp 1 vs dpp4 Inhibitors GLP-1 Agonists | June 2021 | Clinical Corner SGLT2 inhibitor versus DPP-4 inhibitor

Jul 16, 2026 FDA Publishes All 7 Briefing Documents Ahead of the July 2026 PCAC Meeting The FDA has posted all seven scientific briefing documents for the July 2324, 2026 Pharmacy Compounding Advisory Committee meeting an unusually clear window into the agency's current thinking on peptide safety, efficacy, and characterization

Elrick et al

Here are answers to the most common concerns we hear

How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoid treatment

The paper cites estimates that purchasers (including insurers and patients) may be paying as much as 20 percent more than the cash price of a given generic drug because of practices by PBMs and other intermediaries such as wholesalers